par Viromed Medical AG (isin : DE000A3MQR65)
EQS-Adhoc: Viromed Medical AG seeks extensive cooperation with a major global Group
EQS-Ad-hoc: Viromed Medical AG / Key word(s): Alliance
Viromed Medical AG seeks extensive cooperation with a major global Group
11-Dec-2024 / 21:45 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Viromed Medical AG seeks extensive cooperation with a major global Group
Pinneberg, 11 December 2024 - Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; ‘Viromed’; the ‘Company’) is seeking an extensive cooperation with a major global Group that is also active in the pharmaceutical sector. Based on today's discussions, the subject of the cooperation will be in particular the granting of a worldwide licence in favour of Viromed Medical AG for the application of cold atmospheric pressure plasma in medicine. Subject to a contractual agreement, which is expected within the next three months, Viromed expects to generate initial revenues from the use of cold atmospheric pressure plasma in the low double-digit million range as early as the second half of the 2025 financial year.
Another subject of the negotiations for the establishment of an extensive cooperation is a possible participation of the global Group in Viromed or, conversely, a participation of Viromed in portfolio companies of the global Group. However, decisive negotiations on the essential terms of the respective participations are still pending.
Viromed will inform the capital market about the further progress of the negotiations on the intended cooperation in accordance with its legal obligation.
Contact Viromed Medical AG
Uwe Perbandt
CEO
Flensburger Straße 18
25421 Pinneberg
E-Mail: kontakt@viromed-medical.de
www.viromed-medical-ag.de
End of Inside Information
11-Dec-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Viromed Medical AG |
| Flensburger Straße 18 | |
| 25421 Pinneberg | |
| Germany | |
| Phone: | +49 4101 809960 |
| E-mail: | kontakt@viromed-medical.de |
| Internet: | https://www.viromed-medical-ag.de/ |
| ISIN: | DE000A3MQR65 |
| WKN: | A3MQR6 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf (Primärmarkt), Frankfurt (Basic Board), Hamburg |
| EQS News ID: | 2049425 |
| End of Announcement | EQS News Service |
2049425 11-Dec-2024 CET/CEST